High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients-Reference-Cited by-同舟云学术

High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients

Published:2017-04 Issue:4 Volume:49 Page:e317-e317
ISSN:2092-6413
Container-title:Experimental & Molecular Medicine
language:en
Short-container-title:Exp Mol Med

Author:

Cho Sung-Yup,Park Changho,Na Deukchae,Han Jee Yun,Lee Jieun,Park Ok-Kyoung,Zhang Chengsheng,Sung Chang Ohk,Moon Hyo Eun,Kim Yona,Kim Jeong Hoon,Kim Jong Jae,Khang Shin Kwang,Nam Do-Hyun,Choi Jung Won,Suh Yeon-Lim,Kim Dong Gyu,Park Sung Hye,Youn Hyewon^ORCID,Yun Kyuson,Kim Jong-Il^ORCID,Lee Charles,Paek Sun Ha,Park Hansoo

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://www.nature.com/articles/emm20179.pdf

Reference44 articles.

1. Han SJ, Yang I, Tihan T, Prados MD, Parsa AT . Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol 2010; 96: 313–320.

2. Feigin IH, Gross SW . Sarcoma arising in glioblastoma of the brain. Am J Pathol 1955; 31: 633–653.

3. Kozak KR, Mahadevan A, Moody JS . Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome. Neuro Oncol 2009; 11: 183–191.

4. Actor B, Cobbers JMJL, Buschges R, Wolter M, Knobbe CB, Lichter P et al. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components. Genes Chromosomes Cancer 2002; 34: 416–427.

5. Grant JW, Steart PV, Aguzzi A, Jones DB, Gallagher PJ . Gliosarcoma: an immunohistochemical study. Acta Neuropathol 1989; 79: 305–309.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling divergent treatment prognoses in IDHwt-GBM subtypes through multiomics clustering: a swift dual MRI-mRNA model for precise subtype prediction;Journal of Translational Medicine;2024-06-18

2. TGIF2 is a potential biomarker for diagnosis and prognosis of glioma;Frontiers in Immunology;2024-02-26

3. Primary Intracranial Gliosarcoma: Is It Really a Variant of Glioblastoma? An Update of the Clinical, Radiological, and Biomolecular Characteristics;Journal of Clinical Medicine;2023-12-22

4. TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcoma;Neuro-Oncology Advances;2023-12-19

5. Pediatric gliosarcoma, a rare central nervous system tumor in children: Case report and literature review;Heliyon;2023-11